I am nearly speechless by the stupidity and ill-conceived arrogance of industry scientists who are playing havoc with my world and yours.
Read this for yourself and see if you do not believe that you need strong allies to fight this madness back into the nightmare it came from.
That ally is the Natural Solutions Foundation. Give us the voice and give us the strength to carry this battle forward by making sure that you are on the distribution list of the free Health Freedom eAlerts (sign up on our home page, www.HealthFreedomUSA.org) and by forwarding the eAlerts to your entire list and asking them to take the action steps therein.
This madness MUST stop.
Yours in health and freedom,
Dr. Rima
Rima E. Laibow, MD
Medical Director
Natural Solutions Foundation
www.HealthFreedomUSA.org
www.GlobalHealthFreedom.org
www.NaturalSolutionsFoundation.org
www.Organics4U.org
www.NaturalSolutionsMarketPlace.org
www.NaturalSolutionsMedia.tv
Invasion of the warrior insects
Clive Cookson
Financial Times, October 11 2008
Scientists are about to unleash a new weapon in mankind’s running battle
against insect pests: a genetically modified flying army. The first
commercial release of GM insects, to protect US cotton fields from the
voracious pink bollworm, is expected within the next two years. The second
target will be the mosquito that spreads dengue fever in Asia.
This new airborne offensive is being mounted from a business park near
Abingdon, Oxfordshire, where a set of low-key laboratories houses the
world’s leading centre for GM insect development. Oxitec, a private company
spun out of Oxford University in 2002, holds tens of thousands of moths,
mosquitoes and flies in its insectaries. They are undergoing genetic
engineering as part of the fight against agricultural pests and carriers of
human disease.
GM is being deployed to extend the “sterile insect” technique that has
already successfully eradicated pests such as screw-worms and Mediterranean
fruit flies (medflies) in parts of north America. The idea is that vast
numbers of sterile yet virile males – at least 10 times as many as the wild
population – are released in infected areas. These sterile newcomers swamp
the native males, mating with all available females, which then fail to
produce any offspring.
Until now, insects have been sterilised before release by old-fashioned
irradiation from radioactive isotopes. But this is a crude technique that
works only on some species. “It doesn’t work for mosquitoes because a
radiation dose big enough to sterilise the insect will also incapacitate or
kill it,” says Luke Alphey, founder and research director of Oxitec.
With colleagues at Oxford University he discovered how to achieve the same
effect more gently and specifically, by inserting a “dominant lethal” gene
into the insects. “The males produce viable sperm which will fertilise the
egg, but the embryo [larva] dies in development,” says Alphey, who left the
university this year to work full time for the company.
“Of course the system needs to be reversible, so that we can breed the
insects in the first place,” he adds. This is achieved by designing the
lethal gene so that it can be suppressed by adding the antibiotic
tetracycline to the captive insects’ diet. In the absence of tetracycline,
the larvae die.
The lab insects live in clear plastic containers of various shapes,
typically about the size of an archive box. Some have fine mesh or gauze on
one side. Fruit flies, for example, lay their eggs on the mesh, where they
can easily be collected by lab staff.
Female mosquitoes receive what’s known as their “blood meal”, which they
need to breed, through the gauze. Genevieve Labbe, who is in charge of the
mosquito breeding programme, gives them horse blood heated to 37Æ’C, twice a
week. “First we blow into the cage to tell them there’s something to bite,”
she explains. Carbon dioxide in the breath alerts the insects to the
presence of a warm-blooded animal.
The mosquitoes, which have been sitting or flying lethargically around their
box, begin buzzing energetically in response to Labbe’s breath. Then a
cylinder of warm blood, with one end covered with sausage skin, is placed
against the gauze – and the mosquitoes gorge themselves.
Oxitec’s highest-profile project is to attack Aedes aegypti mosquitoes, the
carriers of dengue fever, which afflicts an estimated 100m people every
year. The work is funded with a $5m grant from the Bill & Melinda Gates
Foundation, part of the charity’s drive to reduce the toll from tropical
diseases.
“Both the incidence and severity of dengue are increasing,” warns Alphey.
“There are no drugs or vaccine, and $1bn has been spent – largely
ineffectively – on dengue control through insecticide fogging and site
sanitation.” (The mosquitoes breed in small rainwater pools, such as those
that form in discarded tyres.)
The Malaysian government is collaborating with Oxitec to run a field trial
with GM insects on Pulau Ketam, an island east of Kuala Lumpur inhabited
mainly by Chinese fishing families. Its relative isolation makes Pulau Ketam
a good test site, because were Aedes aegypti to be suppressed locally, the
success would not be masked by mosquitoes moving in from elsewhere. But some
residents are objecting to what they call “warrior” mosquitoes.
“What else will the ‘warrior’ mosquitoes kill?” asked Saw Lek, a retired
teacher quoted in the South China Morning Post. “We fear, once released,
there is no way to control the new mosquito if anything goes wrong.”
There are also objectors further afield. Mae-Wan Ho, director of the
Institute of Science in Society, based in London, calls the use of
“terminator mosquitoes” to control dengue “dangerous and costly”. She
believes there is a risk of the lethal genes moving from the released GM
mosquitoes into other organisms and disrupting the already fragile
environmental balance.
But Oxitec scientists insist their GM mosquitoes are environmentally benign.
First, they argue, only the non-biting males are released; they are easily
sorted from the females in the breeding facility because their pupae are
smaller.
“The natural population density of Aedes aegypti is not high,” says Alphey.
“For a city of 1m people you are probably talking about releasing 10-20
mosquitoes per person per week. I don’t think anyone would notice the
increase in the mosquito population.”
He points out too that Aedes aegypti, like the other pests targeted by
Oxitec, is not a native species (it originates in Africa) but has been
spread around the world by human activities. Its eradication would not
disrupt any local ecosystems. “There is no breeding route into a wild
population,” Alphey insists. And if the terminator gene does inadvertently
get into wild mosquitoes, it “absolutely will not spread”, because any
insects carrying it would not survive.
The promise to keep genetic modification out of the wild population may make
the Oxitec technology more acceptable to sceptics than other ways of using
GM insects, which are being studied but are further from commercial
application. Scientists at Imperial College London, for example, plan
permanently to change the genetic make-up of wild mosquitoes, so that they
can no longer transmit a human pathogen such as the malaria parasite.
Safe or not, GM technology will get nowhere without winning over the people
living near release sites, warns Anthony Wilson, an expert on insect-borne
disease at the UK-based Institute of Animal Health. “If you can see a
facility releasing clouds of mosquitoes, you’ll want to be very sure that
you are not just being used for experimental purposes,” says Wilson. In the
1970s, long before scientists could genetically engineer insects, the World
Health Organisation and the Indian government had to cancel an ambitious
dengue control project after local newspapers caused a furore with erroneous
claims that it was a camouflaged US germ warfare experiment.
In the US, Oxitec’s pink bollworm project is not meeting hostility, partly
because American public opinion is less suspicious of genetically modified
organisms than Asian and European. Another reason is that the GM insects
released in the US would replace insects sterilised by irradiation in the
fight against cotton bollworm, rather than adding millions of new insects to
the existing population. “We have had three years of field trials, releasing
our GM pink bollworm from the air over cotton in Arizona,” says David
Brooks, Oxitech chief executive. “We had a very positive environmental
impact report [from the US Department of Agriculture] and we could go into
commercial operation next year or in 2010.”
A bigger prize in the agricultural sector would be the medfly, a scourge of
fruit-growers worldwide. Oxitec hopes the US government will eventually
adopt GM technology to replace the irradiation facilities that it is funding
in central America to push medfly further away from the US. The
sterilisation plant in Guatemala produces a staggering 2bn sterile flies
every week – that’s 20 tonnes of living insect.
Once the GM medflies have proved themselves in field trials, the US
authorities, nervous about the potential security risks posed by radioactive
sources, may indeed prefer the cleaner and simpler technique of genetic
sterilisation. But it is hard to imagine GM insects being released in
Britain or Europe for the foreseeable future. If activists are determined to
trash static biotech crops, imagine the uproar that would greet GM on wings.
Clive Cookson is the FT’s science editor.
http://www.gmfreeireland.org/news/index.php